ZENTALIS PHARMACEUTICA
1.1800
14-May-25 10:22:19
15 minutes delayed
Stocks
-0.0300
-2.48%
Today's range
1.1800 - 1.2400
ISIN
N/A
Source
NASDAQ
-
Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer
13 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2023 17:00:41 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
01 Feb 2023 07:01:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2023 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2022 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference
08 Nov 2022 07:01:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2022 17:38:22 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces First ZN-c3 Clinical Development Collaboration with Pfizer
24 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
17 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Oct 2022 17:32:42 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer
27 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Dr. Carrie Brownstein as Chief Medical Officer
19 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors
12 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2022 17:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
31 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
09 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2022 17:10:35 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary
27 Jun 2022 07:00:00 By Nasdaq GlobeNewswire